Imagine a tiny, high-pressure jet of liquid that can push medicine into your skin without using a needle. This device first scans your skin to see how thick or tough it is, then adjusts its power automatically to get the dose exactly where it needs to go. It's like a smart printer for medicine that ensures every shot is perfect and painless.
Needle-based injections cause patient anxiety, risk infection, and create massive environmental waste. Additionally, targeting the dermis layer accurately is technically difficult with traditional needles.
The BoldJet, a portable needle-free injector using thermocavitation microjets with integrated skin-sensing and real-time depth monitoring.
If you are a vaccine manufacturer dealing with low patient compliance due to needle phobia — this project developed the BoldJet device that provides a safer, needle-free alternative for delivering medications into the skin.
If you are a medical aesthetics clinic dealing with inconsistent results from manual skin treatments — this project developed a system with real-time monitoring of injection depth and volume to ensure precise delivery of beauty products.
If you are a medical device distributor dealing with the environmental waste of millions of used needles — this project developed a portable, needle-free injector that eliminates needle contamination entirely.
Based on available project data, the specific unit price or production cost of the device is not disclosed.
The project is currently in the development and validation phase with a prototype device, but the coordinator is refining the roadmap for first market access.
Based on available project data, the technology is being developed by FlowBeams BV, but specific patent or licensing terms are not listed.
The team is currently improving their strategy and roadmap towards first market access to address regulatory requirements for medical injections.
The project runs from 2024-07-01 to 2027-06-30, indicating that full commercialization is expected following this period.
The project is led by a single SME, FlowBeams BV from the Netherlands, which holds 100% of the industry ratio. This lean structure suggests a fast-moving, agile development process focused on commercialization, supported by a 2.5 million EUR EU grant.
Contact FlowBeams BV in the Netherlands
Contact us to explore licensing opportunities for needle-free injection technology.
